Arcturus Therapeutics Founder Joseph Payne Welcomes Court Decision to Set Date and Agenda of Extraordinary General Meeting to Vote for New Board Members

SAN DIEGO, Calif., May 14, 2018 (GLOBE NEWSWIRE) — Joseph Payne, Founder and largest shareholder of Arcturus Therapeutics Ltd. (NASDAQ:ARCT) (“Arcturus” or the “Company”), owning approximately 13.7% of the issued and outstanding shares, yesterday welcomed the Israeli Court’s (the “Court”) decision to uphold shareholders’ rights by sanctioning an Extraordinary General Meeting (“EGM”) of shareholders for this June.

Share this post